Sanofi

Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

Record

Field	Value
Representation	alpha-profile-markdown-v3
Protocol	Alpha Governance Facts Protocol 0.1
Schema	alpha.governance.entity.public.v1
Record version	public-1
Canonical entity	alpha:company:6f05ca0c-a52c-469e-bd04-7efad28236e7
Entity type	Company
Canonical URL	https://registry.alpha.ac/companies/sanofi
Publication	PUBLISHED
Verification	source_reported
Verification schema	alpha-verification-states-v1
Ownership	unclaimed
Published claims	35
Claims under review	2
Evidence records	5
Conflicts	0
Conflicts in internal review	0
Observed	2026-09-19T04:47:40.119295+00:00
Last reviewed	2026-09-19T04:47:40.119295+00:00

Identity

Legal name: Sanofi
Display name: Sanofi

Leadership

Frédéric Oudéa: Chairman of the Board of Directors. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Anne-Françoise Nesmes: Independent director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Antoine Yver: Independent director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Barbara Lavernos: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Belén Garijo: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Carole Ferrand: Independent director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Christel Heydemann: Independent director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Christophe Babule: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Clotilde Delbos: Independent director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Emile Voest: Independent director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Humberto De Sousa: Director representing employees. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Jean-Paul Kress: Independent director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
John Sundy: Independent director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Lise Kingo: Independent director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Rachel Duan: Independent director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Wolfgang Laux: Director representing employees. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2.
Belén Garijo: Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3.
Brendan O'Callaghan: Executive Vice President, Manufacturing & Supply. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3.
François Roger: Executive Vice President, Finance. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3.
Jamie Haney: Executive Vice President, General Counsel. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3.
Manuela Buxo: Executive Vice President, Specialty Care. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3.
Natalie Bickford: Executive VP & Chief People Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4.
Olivier Charmeil: Executive Vice President of General Medicines. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4.
Paul Hudson: CEO & Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4.
Paulo Fontoura: Executive Vice President, Head of Research & Development. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3.
Pierre Chancel: Senior Vice President of Global Diabetes and Senior Vice President of Global Marketing. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4.
Roy Papatheodorou: Executive VP & General Counsel. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4.
Thomas Grenier: Executive Vice President, General Medicines. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3.
Thomas Triomphe: Executive Vice President, Vaccines. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3.
Véronique Jaillet: Executive Vice President, Chief People Officer, ad interim. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3.

Roles

PUBLISHED

Governance

NOT_ASSERTED

Board committees

PUBLISHED

Financials

NOT_ASSERTED

Workforce

NOT_ASSERTED

Market and index context

CAC 40 (PX1). Valid from: 2026-06-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:5.

Legal Name

Sanofi. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:1.

Headquarters

US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Entity Status

Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:1.

Official Website

https://www.sanofi.com. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.

Published Fact

US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:1.
Healthcare. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:1.

Coverage states

Field	Value
Identity	PUBLISHED
Business	PUBLISHED
Leadership	PUBLISHED
Board and committees	PUBLISHED
Governance	NOT_ASSERTED
Financials	NOT_ASSERTED
Workforce	NOT_ASSERTED
Ownership	NOT_ASSERTED
Ratings	NOT_PUBLISHED
Market and index context	PUBLISHED

Public sources

alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:1: Alpha canonical company public projection.
alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:2: Sanofi Board of Directors.
alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:3: Sanofi Executive Committee press release 21 July 2026.
alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:4: Sanofi SA key executives.
alpha:evidence:company:6f05ca0c-a52c-469e-bd04-7efad28236e7:5: CAC 40.

Rights

Field	Value
public_retrieval	allowed
agent_retrieval	allowed
redistribution	not_granted
model_training	not_granted
commercial_use	not_specified
relationship_pathfinding	not_granted
direct_contact	not_granted

Limitations

Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
Only explicitly published canonical company identity and current confirmed public roles are included.
Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
This Company Profile is an identity and evidence record, not an Alpha rating.

Alternate representations

Canonical profile
Public Markdown
Public JSON
JSON-LD
MCP resource: alpha://companies/sanofi at https://mcp.alpha.ac/mcp